David Loew
Vorstandsvorsitzender bei IPSEN
Vermögen: 61 001 $ am 30.04.2024
Aktive Positionen von David Loew
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IPSEN | Direktor/Vorstandsmitglied | 01.07.2020 | - |
Vorstandsvorsitzender | 01.07.2020 | - | |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Vorsitzender | 30.07.2020 | - |
European Federation of Pharmaceutical Industries & Assoc | Direktor/Vorstandsmitglied | - | - |
G5 Santé | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von David Loew
Ehemalige bekannte Positionen von David Loew
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SANOFI | Corporate Officer/Principal | 01.07.2013 | 15.06.2020 |
GAVI Alliance | Direktor/Vorstandsmitglied | - | - |
ROCHE HOLDING AG | Corporate Officer/Principal | 01.07.2013 | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Ausbildung von David Loew
University of St. Gallen | Masters Business Admin |
Statistik
International
Frankreich | 5 |
Schweiz | 4 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 6 |
Miscellaneous | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ROCHE HOLDING AG | Health Technology |
SANOFI | Health Technology |
IPSEN | Health Technology |
Private Unternehmen | 5 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
GAVI Alliance | Miscellaneous |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
European Federation of Pharmaceutical Industries & Assoc | Commercial Services |
G5 Santé |
- Börse
- Insiders
- David Loew
- Erfahrung